Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia [Phase 3]
Phase 3 study of GP40141 in immune thrombocytopenia is ongoing, with a focus on efficacy, safety, and immunogenicity; current status is ACTI…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) [Phase 2]
This notice reports the completion of a Phase 2 study of SKI-O-703, a SYK inhibitor, in persistent and chronic immune thrombocytopenia and t…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Safety Study of AMG 531 in Japanese Subjects With ITP [Phase 2]
Phase 2 safety study of romiplostim (AMG 531) in Japanese subjects with immune thrombocytopenia has completed. The study evaluated thrombocy…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347 [Phase 1]
This first-in-human Phase 1 trial of PF-06755347 evaluating safety, tolerability, and pharmacokinetics was terminated, and results have been…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients [Phase 3]
Phase 3 study evaluating safety and immunogenicity of long-term GNR-069 therapy in immune thrombocytopenia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of Huaiqihuang Granule in children with chronic primary immune thrombocytop…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe
A European clinical trial evaluating thrombopoietin receptor agonists for adults with primary immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Short-course High-dose Prednisone and Dexamethasone in Children With ITP [Phase 4]
Phase 4 trial in children with immune thrombocytopenia evaluating a short course of high-dose prednisone and dexamethasone; the study is cur…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP) [Phase 1, Phase 2]
This clinical trial update evaluates the pharmacokinetics and pharmacodynamics of romiplostim in patients with immune thrombocytopenia (ITP)…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP) [Phase 3]
Phase 3 clinical trial update evaluating the efficacy and safety of romiplostim in adults with persistent or chronic immune thrombocytopenia…
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: The DART Study- Daratumumab Treatment in ITP [Phase 2]
Phase 2 clinical trial evaluating daratumumab for immune thrombocytopenia (ITP) is ongoing with status unknown.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura [Phase 2]
Phase 2 trial update evaluating eltrombopag with pulsed dexamethasone for immune thrombocytopenia (idiopathic thrombocytopenic purpura) has …
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP) [Phase 2]
This Phase 2a trial of BIVV020 in adults with persistent or chronic immune thrombocytopenia has completed, with results posted in February 2…
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP) [Phase 3]
Phase 3 trial of Rozanolixizumab in persistent or chronic primary immune thrombocytopenia was terminated; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-29Clinical Trial Update: Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia [Phase 2]
A Phase 2 trial evaluating safety, tolerability, and efficacy of UCB7665 in subjects with primary immune thrombocytopenia has been completed…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 2]
Phase 2 trial updating teriflunomide for steroid-resistant/relapse immune thrombocytopenia is in progress with unknown status in the listing…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 2]
Phase 2 trial exploring teriflunomide plus danazol for steroid-resistant/relapsed immune thrombocytopenia is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: A Study of Zanubrutinib in Patients With ITP [Phase 2]
Phase 2 trial update of Zanubrutinib in immune thrombocytopenia (ITP) completed.
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial [Phase 2]
A Phase 2 randomized trial compares high-dose dexamethasone plus hetrombopag versus high-dose dexamethasone alone as frontline therapy for n…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia [Phase 3]
Phase 3 trial evaluating subcutaneous belimumab or placebo added to rituximab for persistent or chronic immune thrombocytopenia; currently r…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: IgIV Plus Prednisone vs High-dose Dexamethasone for ITP [Phase 3]
Phase 3 trial comparing intravenous immunoglobulin plus prednisone against high-dose dexamethasone for immune thrombocytopenia is currently …
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP) [Phase 3]
Phase 3 trial investigating Rozanolixizumab for adult primary immune thrombocytopenia has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP) [Phase 3]
Phase 3 trial evaluating Rozanolixizumab in adults with persistent or chronic primary immune thrombocytopenia was terminated, with results p…
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP [Phase 2]
A Phase 2 trial evaluating ARGX-113 for safety, efficacy, and pharmacokinetics in adults with primary immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia [Phase 2]
A Phase 2 clinical trial is evaluating low-dose baricitinib combined with high-dose dexamethasone for newly diagnosed immune thrombocytopeni…